These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14351141)

  • 1. The action of poly-lysine on the conversion of fibrinogen into fibrin by coagulase thrombin.
    BIEZUNSKI N; SHAFRIR E; DE VRIES A; KATCHALSKI E
    Biochem J; 1955 Jan; 59(1):55-8. PubMed ID: 14351141
    [No Abstract]   [Full Text] [Related]  

  • 2. Formation and properties of fibrin clots resulting from staphylocoagulase (SC) action.
    Kopeć M; Wegrzynowicz Z; Budzyński AZ; Jeljaszewicz J; Latallo ZS; Lipiński B; Kowalski E
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):475-86. PubMed ID: 5590240
    [No Abstract]   [Full Text] [Related]  

  • 3. [The rapid determination of fibrin and fibrinogen split products with a bedside thrombin coagulase time test in obstetric coagulopathies (author's transl)].
    Kastendieck E; Barthels M
    Geburtshilfe Frauenheilkd; 1974 Sep; 34(9):758-62. PubMed ID: 4437565
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reliability of tests for fibrinogen (fibrin) degradation products in plasma with thrombin coagulase, reptilase and thrombin clotting time (author's transl)].
    Wenzel E; Holzhüter H; Muschietti F; Angelkort B; Ochs HG; Pusztai-Markos S; Nowak H; Stürner H
    Dtsch Med Wochenschr; 1974 Apr; 99(15):746-56. PubMed ID: 4858105
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological effects of fibrinogen-fibrin degradation products.
    Larrieu MJ; Dray L; Ardaillou N
    Thromb Diath Haemorrh; 1975 Dec; 34(3):686-92. PubMed ID: 1108283
    [No Abstract]   [Full Text] [Related]  

  • 6. [Participation of sialic acid residue in the fibrinogen-fibrin conversion by thrombin].
    Akihama S; Matsuda Y; Fukase T; Yamanaka A; Okude M
    Yakugaku Zasshi; 1995 Jul; 115(7):537-42. PubMed ID: 7562401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrinogen derivatives appearing in calf plasma after the action of thrombin and endotoxin].
    Benabid Y; Laurent M; Concord E; Suscillon M
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:24-30. PubMed ID: 4587012
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for thrombin enhancement of fibrin polymerization that is independent of its catalytic activity.
    Kaminski M; Siebenlist KR; Mosesson MW
    J Lab Clin Med; 1991 Mar; 117(3):218-25. PubMed ID: 2002278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on blood coagulation. I. Factors involved in the conversion of prothrombin into thrombin and of fibrinogen into fibrin].
    LONG LA; COLPRON G
    Union Med Can; 1961 Jan; 90():22-9. PubMed ID: 13763333
    [No Abstract]   [Full Text] [Related]  

  • 10. FIBRINOGEN CLOTTING AND FIBRINO-PEPTIDE FORMATION BY STAPHYLOCOAGULASE AND THE COAGULASE-REACTING FACTOR.
    DRUMMOND MC; TAGER M
    J Bacteriol; 1963 Mar; 85(3):628-35. PubMed ID: 14042942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conversion of fibrinogen to fibrin. V. Influence of ionic strength and thrombin concentration on the effectiveness of certain reversible inhibitors.
    SHULMAN S; HERWIG WC; FERRY JD
    Arch Biochem Biophys; 1951 Jul; 32(2):354-8. PubMed ID: 14857755
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of the inhibitory effect of ethylenediaminetetra-acetic acid on the thrombin-fibrinogen reaction.
    Bithell TC
    Biochem J; 1964 Nov; 93(2):431-9. PubMed ID: 4953832
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrinogen degradation products and fibrinogen to fibrin conversion.
    Arnesen H
    Scand J Haematol Suppl; 1971; 13():245-52. PubMed ID: 5290685
    [No Abstract]   [Full Text] [Related]  

  • 14. Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties.
    Helms CC; Kapadia S; Gilmore AC; Lu Z; Basu S; Kim-Shapiro DB
    Blood Coagul Fibrinolysis; 2017 Jul; 28(5):356-364. PubMed ID: 27755019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on fibrinogen, fibrin, and blood coagulation of proteolytic extracts from fruits of Pseudananas macrodontes, Bromelia balansae, and B. hieronymi (Bromeliaceae) in comparison with bromelain.
    Errasti ME; Prospitti A; Viana CA; Gonzalez MM; Ramos MV; Rotelli AE; Caffini NO
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):441-9. PubMed ID: 26886361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen clottability and fibrin formation.
    Alexander B
    Thromb Diath Haemorrh Suppl; 1966; 20():191-200. PubMed ID: 4226518
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of fibronectin on fibrinogen conversion into fibrin].
    Litvinov RI; Zubairov DM
    Biokhimiia; 1988 Jul; 53(7):1203-13. PubMed ID: 3179367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of fibrin formation in exercise-induced activation of coagulation.
    Vogt A; Hofmann V; Straub PW
    Am J Physiol; 1979 Apr; 236(4):H577-9. PubMed ID: 434223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble unclottable complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology.
    Lipinski B; Wegrzynowicz Z; Budzynski AZ; Kopeć M; Latallo ZS; Kowalski E
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):65-77. PubMed ID: 5584961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.